Craft
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
banner
Caribou Biosciences financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.

Stock Price

$6.1

2024-01-31

Market Capitalization

$542.1 M

2024-01-31

Revenue

$13.9 M

FY, 2022

CreditSafe Score

?
Score changed on Feb 29, 2024
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn more

Financial Statements

USDFY, 2021FY, 2022
Revenue9.6M13.9M
General and administrative expense24.3M38.0M
Operating expense total76.6M120.3M
EBIT(67.0M)(106.4M)
EBIT margin, %-697.8%-768.2%
Interest income148.0K
Interest expense8.0K
Pre tax profit(66.6M)(99.4M)
Income tax expense321.0K70.0K
Net Income(66.9M)(99.4M)
EPS(1.6)

Footer menu